Welcome to LookChem.com Sign In|Join Free

CAS

  • or

117678-37-2

Post Buying Request

117678-37-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

117678-37-2 Usage

Description

Levofloxacin N-Oxide is a derivative of the antibiotic levofloxacin, which is formed through the process of oxidation in the body. It exhibits similar antimicrobial activity to levofloxacin and has been studied for its potential as a novel antimicrobial agent. Levofloxacin N-Oxide has shown promising results in inhibiting the growth of various bacteria, including drug-resistant strains, and may have a lower potential for causing antibiotic resistance compared to the parent compound.

Uses

Used in Pharmaceutical Industry:
Levofloxacin N-Oxide is used as an antimicrobial agent for its ability to inhibit the growth of various bacteria, including drug-resistant strains. Its similar antimicrobial activity to levofloxacin and lower potential for causing antibiotic resistance make it a promising candidate for the development of new antibiotics to treat bacterial infections.
Used in Research and Development:
Levofloxacin N-Oxide is used in ongoing research to explore its therapeutic potential and further investigate its antimicrobial properties. This research aims to develop new antibiotics and improve the treatment of bacterial infections, particularly those caused by drug-resistant strains.

Check Digit Verification of cas no

The CAS Registry Mumber 117678-37-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,7,6,7 and 8 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 117678-37:
(8*1)+(7*1)+(6*7)+(5*6)+(4*7)+(3*8)+(2*3)+(1*7)=152
152 % 10 = 2
So 117678-37-2 is a valid CAS Registry Number.

117678-37-2Upstream product

117678-37-2Downstream Products

117678-37-2Relevant articles and documents

N-oxides as antibacterial agents

-

, (2008/06/13)

PCT No. PCT/EP96/02171 Sec. 371 Date Nov. 19, 1997 Sec. 102(e) Date Nov. 19, 1997 PCT Filed May 20, 1996 PCT Pub. No. WO96/38417 PCT Pub. Date Dec. 5, 1996The present invention relates to new antibacterial compositions, in particular orally administrable compositions, based on N-oxides of saturated nitrogen-containing heterocycles which are substituted by quinolonecarboxylic acids or naphthyridonecarboxylic acids, and to new active compounds and their preparation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 117678-37-2